Non-Autogenous Innovative Reconstruction Method Following Mandibulectomy

• Main Authors: Bahaa Haj Yahya, Eli Rosenfeld, Gavriel Chaushu, Ilana Kaplan, Yehonantan Ben-Zvi, Yafit Hamzani
• Format: Article
• Language: English
• Published: MDPI AG 2020-06-01
• Series: Medicina
• Subjects: ameloblastoma; mandible; bone block; allogenic; autogenic; rhBMP
• Online Access: https://www.mdpi.com/1010-660X/56/7/326

Background: Plexiform ameloblastoma is a locally aggressive odontogenic tumor, rare in the anterior mandible. The treatment of choice is resection with 1–3 cm free margins. In most of reported cases, the affected mandible is reconstructed by autogenic bone graft or osseocutaneous microvascular free flap in order to return function and esthetics. Case description: A 2 cm diameter exophytic ameloblastoma, located in the anterior mandible of a 50-year-old male was resected and reconstructed in a unique manner—allogenic bone block, recombinant human bone morphogenetic protein (rhBMP) and xenograft particles via transcutaneous submental approach. After bone maturation, dental implants were placed and restored by fixed prosthetics. Practical implications: Mandible reconstruction modalities have a crucial influence on patient quality of life, function and esthetics. Allogenic bone block combined with rhBMP and xenograft particles can replace the traditional autogenous bone in certain circumstances. A submental transcutaneous “tent pole” approach can improve the success rate of the reconstruction procedure.